Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (16 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net revenue
335
403
370
305
283
282
298
Cost of revenue
241
292
283
252
242
252
271
Gross Profit
94
111
87
54
41
30
27
Product development
20
24
21
19
20
18
16
Sales and Marketing
17
17
14
15
16
15
12
General and administrative
18
20
23
16
17
17
17
Impairment of goodwill
0
0
0
92
96
0
0
Operating loss
39
49
29
-89
-108
-19
-19
Interest income
0
0
0
0
0
0
0
Interest expense
-4
-4
-4
-5
-4
-4
-1
Other income, net
2
0
0
0
1
3
0
Loss before income taxes
37
45
24
-94
-110
-20
-19
(Provision for) benefit from taxes
-16
-18
-11
27
-36
0
0
Net loss
21
27
13
-67
-146
-20
-19
Basic
13
0
0
0
0
0
0
Diluted
13
0
0
0
0
0
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Sep 12, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (29 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
132
69
90
84
60
54
Marketable securities
n/a
35
37
38
39
0
0
Accounts receivable, net
n/a
48
53
38
42
46
47
Deferred tax assets
n/a
10
8
7
0
0
0
Prepaid expenses and other assets
n/a
6
8
5
12
12
7
Total current assets
n/a
231
174
178
177
118
108
Property and equipment, net
n/a
9
9
10
11
9
8
Goodwill
n/a
212
243
150
55
56
56
Deferred tax assets, noncurrent
n/a
6
8
40
2
0
0
Other intangible assets, net
n/a
66
72
50
31
19
10
Other Assets, Noncurrent
n/a
1
1
1
0
3
11
Total assets
n/a
525
507
430
277
205
193
Liabilities and owners' equity
Accounts payable
n/a
23 23300000
23 22870000
19 18722000
20 19517000
20 20425000
20 19814000
Accrued liabilities
n/a
33 33238000
29 29462000
31 30903000
28 27854000
27 27146000
28 27705000
Deferred revenue
n/a
3 2531000
3 2553000
2 1638000
1 1175000
1 1208000
1 1200000
Debt
n/a
10 10038000
15 15429000
15 15428000
18 17698000
0 49000
15 15000000
Total current liabilities
n/a
69 69107000
70 70314000
67 66691000
66 66244000
49 48828000
64 63719000
Deferred Revenue, Noncurrent
n/a
0 58000
0 49000
0 239000
0 0
0 0
0 0
Debt, noncurrent
n/a
96 96010000
92 92167000
77 77249000
60 59565000
15 15000000
0 0
Other Liabilities, Noncurrent
n/a
4 4360000
6 6273000
6 6473000
6 5883000
6 5740000
5 4631000
Total liabilities
n/a
170 169535000
169 168803000
151 150652000
132 131692000
70 69568000
68 68350000
Commitments and Contingencies (see Note 9)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 50000
0 43000
0 43000
0 44000
0 45000
0 45000
Additional paid-in capital
n/a
256 255689000
221 220552000
227 226857000
240 239558000
249 249358000
258 257950000
Treasury stock, at cost
n/a
-8 -7779000
-1 -1178000
0 0
0 0
0 0
0 0
Accumulated other comprehensive loss
n/a
0 51000
-1 -1439000
-1 -1012000
-1 -1054000
0 -413000
0 -418000
Accumulated deficit
n/a
107 107378000
120 120379000
53 53007000
-93 -93397000
-113 -113405000
-133 -132825000
Total stockholders' equity
n/a
355 355389000
338 338357000
279 278895000
145 145151000
136 135585000
125 124752000
Total liabilities and stockholders' equity
n/a
525 524924000
507 507160000
430 429547000
277 276843000
205 205153000
193 193102000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Aug 19, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (44 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net loss
21
27
13
-67
-146
-20
-19
Depreciation and amortization
19
27
31
32
26
19
15
Impairment of goodwill
0
0
0
92
96
0
0
Write-off of bank loan upfront fees
0
0
0
1
0
1
0
Provision for sales returns and doubtful accounts receivable
-1
0
0
-1
0
0
1
Stock-based compensation
13
14
13
12
10
10
11
Excess tax benefits from stock-based compensation
-2
-7
0
0
-1
0
0
Gains on sale of investment and domain names
0
0
0
0
-1
-3
0
Other adjustments, net
-2
0
1
0
0
0
0
Accounts receivable
-14
4
-2
15
-3
-4
-2
Prepaid expenses and other assets
0
5
-3
3
-6
0
4
Deferred taxes
-7
-3
3
-31
45
2
0
Other Assets, Noncurrent
0
0
0
0
0
0
-8
Accounts payable
3
6
0
-5
1
2
-1
Accrued liabilities
8
3
-7
-1
0
0
1
Deferred revenue
0
1
0
-1
-1
0
0
Other Liabilities, Noncurrent
0
1
-1
0
-1
0
0
Net cash provided by operating activities
39
78
46
51
18
6
1
Capital expenditures
-3
-5
-2
-1
-5
-3
-2
Business acquisitions
-68
-92
-60
0
-1
-1
0
Other intangibles
0
0
0
-3
-3
0
0
Internal software development costs
-1
-2
-2
-3
-2
-2
-3
Purchases of marketable securities
0
-54
-47
-51
-51
-17
0
Proceeds from maturities of marketable securities
0
19
45
50
50
27
0
Proceeds from Sales of Marketable Securities
0
0
0
0
1
28
0
Purchase of investment
0
0
0
0
0
-3
0
Proceeds from sale of domain names
0
0
0
0
0
3
0
Other investing activities
0
-1
0
0
0
0
0
Net proceeds from issuance of common stock
137
0
0
0
0
0
0
Net cash (used in) provided by investing activities
-72
-135
-67
-7
-11
33
-5
Proceeds from exercise of common stock options
2
17
5
0
3
1
0
Proceeds from bank debt
43
24
6
0
0
0
0
Proceeds from revolving loan facility
0
0
0
0
0
15
0
Principal payments on term loan facility
-3
-4
-5
-8
-13
-78
0
Payment of bank loan upfront fees
0
0
-1
0
0
0
0
Principal payments on acquisition-related notes payable
-15
-11
-3
-8
-3
0
0
Excess tax benefits from stock-based compensation
2
7
0
0
1
0
0
Withholding taxes related to restricted stock net share settlement
0
0
0
0
-2
-1
-2
Repurchases of common stock
-1
0
-44
-6
0
0
0
Net cash used in financing activities
164
33
-43
-22
-14
-63
-2
Effect of exchange rate changes on cash and cash equivalents
0
0
0
0
0
0
0
Net decrease in cash and cash equivalents
131
-23
-64
22
-6
-24
-7
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Sep 12, 2014 n/a
calculated values,
restated on Aug 19, 2015 n/a
calculated values,
restated on Aug 19, 2016 n/a
calculated values,
restated on Aug 19, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo